论文部分内容阅读
目的探讨布地奈德混悬液雾化吸入治疗小儿轻中度喘息性疾病的疗效。方法 40例轻中度喘息性疾病患儿根据治疗药物的不同分为治疗组20例与对照组20例,在常规处理的基础上,治疗组给予布地奈德混悬液雾化吸入治疗,对照组给予甲基强的松龙针治疗。结果两组治疗前FEV1对比无明显差异,治疗后都有明显上升,组间对比有明显差异(P<0.05)。两组治疗前喘息评分对比无明显差异,治疗后都有明显下降,组间对比也有明显差异(P<0.05)。两组不良反应对比无明显差异(P>0.05)。结论布地奈德是一种局部激素,全身性作用极小的药物,治疗小儿轻中度喘息性疾病临床应用价值大。
Objective To investigate the efficacy of inhalation of budesonide suspension in the treatment of infantile mild to moderate asthmatic disease. Methods Forty children with mild to moderate asthmatic disease were divided into treatment group (n = 20) and control group (n = 20). On the basis of routine treatment, the treatment group was treated with budesonide suspension atomization inhalation. The control group Group given methylprednisolone needle treatment. Results Before treatment, there was no significant difference in FEV1 between the two groups. After treatment, there was a significant increase (P <0.05). There was no significant difference between the two groups before the treatment of wheezing score, after treatment there was a significant decline, there was significant difference between groups (P <0.05). No significant difference between the two groups of adverse reactions (P> 0.05). Conclusion Budesonide is a local hormone, a very small systemic drugs, the treatment of mild to moderate wheezing in children with clinical application of great value.